About This Research Study
Influenza (flu) is an infectious disease characterized by the abrupt onset of respiratory and systemic symptoms, such as fever, cough, sore throat, and rhinitis. Research studies are crucial, especially for developing vaccines to protect children, seniors, and people with underlying medical conditions.
Most flu vaccines are generated in embryonated hens’ eggs or in cell lines. In this study, researchers are studying a whether an investigational mRNA vaccine could be an effective alternative to traditional flu vaccine approaches. Meridian is now seeking participants for this study.
- Must be age 18 or older <<Or age of currently enrolling cohort>>
- Can NOT have a history of myocarditis, pericarditis, and/or myopericarditis
- Will receive either an investigational mRNA flu vaccine or an approved seasonal flu vaccine
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.
Submit your information
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.